Literature DB >> 36069916

Implementation of enhanced recovery protocols reduces opioid use in pediatric laparoscopic cholecystectomy surgery.

Goeto Dantes1, Olivia A Keane2, Matthew Margol3, Oluwatoyin Thompson3, Gregory Darville3, Matthew S Clifton4, Kurt F Heiss4.   

Abstract

PURPOSE: Enhanced recovery protocols [ERPs] standardize care and have been demonstrated to improve surgical quality in adults. We retrospectively compared outcomes before and after implementation of ERPs in children undergoing elective laparoscopic cholecystectomy [ELC] surgery.
METHODS: A pediatric-specific ERP was implemented for children undergoing ELC at one [C1] of the two Pediatric Surgical Centers in July 2016. We retrospectively reviewed 606 patients undergoing ELC between July 2014 and December 2019. Of these, 206 patients underwent ELC prior to ERP implementation [Pre-ERP] were compared to 400 patients undergoing ELC managed in the post-ERP implementation period (between January 2017 and December 2019), 21 of which were managed by enhanced recovery protocol. Primary Outcomes included immediate peri-operative and post-operative narcotic use in mean morphine equivalents [MME], narcotics at discharge, complications, nurse calls and returns to system [RTS].
RESULTS: There was a significant decrease in opioid use both post-operatively and at time of discharge in the ERP managed cohort. The MME use during the post-operative period was 0.85 in the in ERP-compliant patients compared to 6.40 in the non-compliant group (p < 0.027). Eighty-six percent of ERP-compliant patients in the study required no narcotics at discharge, which was statistically significant when compared to ERP non-compliant cohort (p < 0.0001). There was also no change in RTS, nurse calls or complications. In addition, in the post-ERP period (2017-2019), a dominant proportion of patients at C1 partially complied with the ERP, resulting in a statistically significantly decrease of opioid use between sites in the post-op period (6.54 vs 10.57 MME) post-ERP (p < 0.001). Similar effects were noted in discharge narcotics.
CONCLUSION: The use of pediatric-specific ERP in children undergoing ELC is safe, effective, and provides compassionate pain control while leading to a reduction in opioid use peri-operatively and at discharge. This improvement occurred without changes in RTS, nursing calls or complications. LEVEL OF EVIDENCE: Level III; Retrospective study.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cholecystectomy; ERAS; ERPs; Fast-track; Opiates

Mesh:

Substances:

Year:  2022        PMID: 36069916     DOI: 10.1007/s00383-022-05195-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   2.003


  15 in total

Review 1.  Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations.

Authors:  Yannick Cerantola; Massimo Valerio; Beata Persson; Patrice Jichlinski; Olle Ljungqvist; Martin Hubner; Wassim Kassouf; Stig Muller; Gabriele Baldini; Francesco Carli; Torvind Naesheimh; Lars Ytrebo; Arthur Revhaug; Kristoffer Lassen; Tore Knutsen; Erling Aarsether; Peter Wiklund; Hitendra R H Patel
Journal:  Clin Nutr       Date:  2013-10-17       Impact factor: 7.324

2.  Decreased opioid prescribing in children using an enhanced recovery protocol.

Authors:  Katherine J Baxter; Heather L Short; Martha Wetzel; Rebecca S Steinberg; Kurt F Heiss; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2019-03-01       Impact factor: 2.545

3.  Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  Kristoffer Lassen; Marielle M E Coolsen; Karem Slim; Francesco Carli; José E de Aguilar-Nascimento; Markus Schäfer; Rowan W Parks; Kenneth C H Fearon; Dileep N Lobo; Nicolas Demartines; Marco Braga; Olle Ljungqvist; Cornelis H C Dejong
Journal:  Clin Nutr       Date:  2012-09-26       Impact factor: 7.324

Review 4.  Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  J Nygren; J Thacker; F Carli; K C H Fearon; S Norderval; D N Lobo; O Ljungqvist; M Soop; J Ramirez
Journal:  Clin Nutr       Date:  2012-09-26       Impact factor: 7.324

5.  ERAS protocol for pediatric laparoscopic cholecystectomy promotes safe and early discharge.

Authors:  Andrew Yeh; Gabriella Butler; Stephen Strotmeyer; Kelly Austin; Mihaela Visoiu; Franklyn Cladis; Marcus Malek
Journal:  J Pediatr Surg       Date:  2019-10-25       Impact factor: 2.545

6.  The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials.

Authors:  Krishna K Varadhan; Keith R Neal; Cornelius H C Dejong; Kenneth C H Fearon; Olle Ljungqvist; Dileep N Lobo
Journal:  Clin Nutr       Date:  2010-01-29       Impact factor: 7.324

7.  Risk factors, complications, and outcomes of gallstones in children: a single-center review.

Authors:  Conor O Bogue; Amanda J Murphy; J Ted Gerstle; Rahim Moineddin; Alan Daneman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-03       Impact factor: 2.839

8.  Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  K Mortensen; M Nilsson; K Slim; M Schäfer; C Mariette; M Braga; F Carli; N Demartines; S M Griffin; K Lassen
Journal:  Br J Surg       Date:  2014-07-21       Impact factor: 6.939

9.  Implementation of an enhanced recovery protocol in pediatric colorectal surgery.

Authors:  Heather L Short; Kurt F Heiss; Katelyn Burch; Curtis Travers; John Edney; Claudia Venable; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2017-05-12       Impact factor: 2.545

Review 10.  Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations.

Authors:  M J Scott; G Baldini; K C H Fearon; A Feldheiser; L S Feldman; T J Gan; O Ljungqvist; D N Lobo; T A Rockall; T Schricker; F Carli
Journal:  Acta Anaesthesiol Scand       Date:  2015-09-08       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.